Algert Global LLC Ardelyx, Inc. Transaction History

Algert Global LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.89 - $9.31 $137,949 - $218,049	23,421 New	23,421 $174,000
Q1 2021 May 14, 2021	SELL	$6.1 - $7.69 $62,512 - $78,807	-10,248 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$5.05 - $7.1 $707,949 - $995,334	-140,188 Reduced 93.19%	10,248 $66,000
Q3 2020 Nov 16, 2020	BUY	$5.25 - $7.08 $269,745 - $363,770	51,380 Added 51.87%	150,436 $790,000
Q1 2020 May 13, 2020	SELL	$4.35 - $8.79 $8,439 - $17,052	-1,940 Reduced 1.92%	99,056 $563,000
Q4 2019 Feb 18, 2020	BUY	$4.23 - $8.29 $325,464 - $637,849	76,942 Added 319.87%	100,996 $758,000
Q3 2019 Nov 14, 2019	BUY	$2.15 - $6.28 $5,332 - $15,574	2,480 Added 11.5%	24,054 $113,000
Q2 2019 Aug 14, 2019	SELL	$2.49 - $3.73 $64,792 - $97,058	-26,021 Reduced 54.67%	21,574 $58,000
Q1 2019 May 01, 2019	SELL	$1.88 - $3.35 $188,641 - $336,142	-100,341 Reduced 67.83%	47,595 $133,000
Q4 2018 Feb 01, 2019	SELL	$1.66 - $4.16 $59,278 - $148,553	-35,710 Reduced 19.45%	147,936 $265,000
Q3 2018 Nov 14, 2018	SELL	$3.75 - $4.65 $2,587 - $3,208	-690 Reduced 0.37%	183,646 $799,000
Q2 2018 Aug 02, 2018	BUY	$3.7 - $5.8 $496,636 - $778,510	134,226 Added 267.86%	184,336 $682,000
Q1 2018 May 03, 2018	BUY	$5.05 - $7.9 $253,055 - $395,869	50,110 New	50,110 $253,000

219

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $815M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.